Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Net Income (2018 - 2025)

Bicycle Therapeutics' Net Income history spans 8 years, with the latest figure at $204.5 million for Q4 2025.

  • For Q4 2025, Net Income rose 60.0% year-over-year to $204.5 million; the TTM value through Dec 2025 reached $5.7 million, down 46.57%, while the annual FY2025 figure was $5.6 million, 46.81% down from the prior year.
  • Net Income reached $204.5 million in Q4 2025 per BCYC's latest filing, up from -$59.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $204.5 million in Q4 2025 to a low of -$79.0 million in Q2 2025.
  • Average Net Income over 5 years is -$17.3 million, with a median of -$31.7 million recorded in 2022.
  • Peak YoY movement for Net Income: surged 378.84% in 2024, then tumbled 129.1% in 2025.
  • A 5-year view of Net Income shows it stood at -$18.0 million in 2021, then tumbled by 93.95% to -$35.0 million in 2022, then crashed by 31.12% to -$45.8 million in 2023, then soared by 378.84% to $127.8 million in 2024, then skyrocketed by 60.0% to $204.5 million in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Net Income are $204.5 million (Q4 2025), -$59.1 million (Q3 2025), and -$79.0 million (Q2 2025).